Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

On April 24, the Centers for Medicare and Medicaid Services announced plans to overhaul the Meaningful Use program by turning to a focus on interoperability. Thus, it only makes sense that the agency ...

Grow Therapy's Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire and Transformation Capital.

Health data company Health Gorilla filed a motion to dismiss a lawsuit from Epic and several healthcare providers alleging inappropriate access to nearly 300,000 patient records. The case highlights ...

On Wednesday, the Centers for Medicare & Medicaid Services launched a new initiative in tandem with the White House and HHS aimed at creating a more patient-centric healthcare ecosystem. As part of ...

Otsuka Pharmaceutical is broadening its scope in rare disease, striking a deal to acquire Jnana Therapeutics and its lead drug candidate, a small molecule on track for pivotal testing in a metabolic ...

A Boehringer Ingelheim drug now has FDA approval as an earlier treatment for lung cancers expressing a certain genetic signature, a regulatory decision handed out under the agency’s new pilot program ...

The millions of people who regularly suffer from heartburn now have a new FDA-approved treatment option, a Phathom Pharmaceuticals drug with a different mechanism of action than older medications that ...

Galapagos believed so strongly in its work developing new cancer cell therapies that it pinned its future on them. This past winter, the Belgian drugmaker unveiled a plan to spin out the rest of the ...

Positive Development, a developmental therapy provider for children with autism, announced Wednesday that it raised $51.5 million in Series C funding. The McLean, Virginia-based company’s model is ...